A connected island

Leading global player has invested $9 bn+ in Irish operations

Pharmaceutical manufacturing in Ireland continues to perform very well contributing strongly to exports and economic growth and provides excellent career opportunities.

Ireland is home to the company’s only global site outside the USA

Medical devices maker chooses Ireland as its European manufacturing hub

This state-of-the-art factory will play a critical role in allowing Dexcom to meet the growing demand for its continuous glucose monitoring systems across key markets in Europe… Factory 4 is being built in the med tech powerhouse region on the West Coast of Ireland, where Dexcom is already making a strong impact in the community.

Pharma giant’s 60-year history of investing in Ireland

The NGSC in Dublin is Novartis’s leading digital science centre globally. This is due to the fact that there is such a large amount of digital talent and a significant tech ecosystem in Ireland... We have an innovative team of data scientists and data managers who are harnessing the power of digital to revolutionise the way that we manage disease and ultimately get our medicines to patients faster.

Company makes Ireland one of its largest international sites

We think that Ireland has really become the gateway to the European Union. There’s so many things that US companies gain from their relationship with Ireland.

50 hires planned for commercial and technical disciplines

Establishing a Dublin presence is a deliberate step in our European expansion. Ireland offers both a sophisticated fintech ecosystem and access to world-class talent, making it an ideal hub for deepening relationships with enterprises in the region.